Medicare utilization — SANTOSH M NAIR (MD)
Calendar year 2023 · data refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Allowed | Payment |
|---|---|---|---|---|---|
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 27,037 | 33 | $0 | $10,810 |
| J1756 | Injection, iron sucrose, 1 mg | 18,202 | 24 | $0 | $2,990 |
| J9271 | Injection, pembrolizumab, 1 mg | 9,002 | 11 | $0 | $390,181 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 4,500 | 51 | $0 | $531 |
| J0897 | Injection, denosumab, 1 mg | 3,841 | 20 | $0 | $70,922 |
Service volume and Medicare payment amounts do not indicate quality of care, patient outcomes, or fraud. Data reflects Medicare fee-for-service only.
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·